Phase II, Safety and Immunogenicity of RAZI Cov Pars (RCP) SARS Cov-2 Vaccine in Adults Aged 18–70 Years; A Randomized, Double-Blind Clinical Trial

Arash Mohazzab, Mohammad Hossein Fallah Mehrabadi, Ali Es‐haghi, Saeed Kalantari, Ladan Mokhberalsafa, Seyed Amin Setarehdan, F. Sadeghi, Ali Rezaei Mokarram, Monireh Haji Moradi, Seyad Hossein Razaz, Maryam Taghdiri, Akram Ansarifar, Mohsen Lotfi, Akbar Khorasani, Mojtaba Nofeli, Safdar Masoumi, Zahra Boluki, Saeed Erfanpoor, Fahimeh Bagheri Amiri, Neda Esmailzadehha, Sara Filsoof, Vahideh Mohseni, Neda Ghahremanzadeh, Shiva Safari, Masoumeh Shahsavan, Shnoo Bayazidi, Maryam Derakhshani, Mohammad Hasan Rabiee, Rezvan Golmoradi-Zadeh, Behnam Khodadoost, Masoud Solaymani–Dodaran, Seyed Reza Banihashemi